Stability, Cutaneous Delivery, and Antioxidant Potential of a Lipoic Acid and α-tocopherol Codrug Incorporated in Microemulsions

Overview

Journal J Pharm Sci

Publisher Elsevier

Specialties Pharmacology
Pharmacy

Date 2014 Jun 26

PMID 24961388

Citations 6

Authors

Siji Thomas

Camila S Vieira

Martha A Hass

Luciana B Lopes

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to assess the skin penetration, stability, and antioxidant effects of a α-tocopherol-lipoic acid codrug. To enhance penetration, we evaluated three microemulsions varying in water content and composition of the oil phase (isopropyl myristate with either monocaprylin or oleic acid). The codrug was incorporated at 1% (w/w). Codrug hydrolysis in the microemulsion increased with increases in time (up to 48 h) and formulation water content (10%-30%, w/w). Microemulsions increased the codrug delivery into viable layers of porcine ear skin by 2.9-7.8-fold compared with a control formulation (20% monocaprylin in isopropyl myristate) after 24 h. Penetration enhancement was influenced by the oil phase, with the formulation containing monocaprylin displaying the most pronounced effect. Antioxidant activity, assessed in skin bioequivalents using the thiobarbituric acid-reactive substances (TBARS) assay, demonstrated that TBARS levels decreased by 39% after treatment with the codrug-containing microemulsion compared with the unloaded formulation. In addition to the codrug, tocopherol (8.2 ± 0.6 μg/cm(2)) was detected in the viable bioequivalent tissues, suggesting that the codrug was partly hydrolyzed after 12 h. Taken together, these results support the potential of nanodispersed formulations containing a tocopherol-lipoic acid codrug to improve skin antioxidant activity.

Citing Articles

Microemulsions Improve the Cutaneous Co-Localization of Lipoic Acid and Quercetin and Antioxidant Effects in Cutaneous Cells and Tissue.

de Sousa Silva M, Passos J, Dare R, Nunes J, Adriani P, Lopes L AAPS PharmSciTech. 2025; 26(3):70.

PMID: 40011308 DOI: 10.1208/s12249-025-03062-2.

Influence of ascorbic acid and α-tocopherol on the autoxidation and in vitro antifungal activity of amphotericin B.

Belhachemi M, Boucherit-Otmani Z, Boucherit K, Belmir S Curr Med Mycol. 2021; 7(1):12-18.

PMID: 34553092 PMC: 8443877. DOI: 10.18502/cmm.7.1.6178.

Mycochemical Screening and Analysis, Antioxidant Activity, and Biochemical Composition of Fermentation Strain Snef1216 ().

Sikandar A, Zhang M, Wang Y, Zhu X, Liu X, Fan H J Anal Methods Chem. 2020; 2020:3073906.

PMID: 32309009 PMC: 7149326. DOI: 10.1155/2020/3073906.

Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis.

de Bastiani F, de Castro Spadari C, de Matos J, Cassone Salata G, Lopes L, Ishida K Front Microbiol. 2020; 10:2976.

PMID: 31998264 PMC: 6965356. DOI: 10.3389/fmicb.2019.02976.

Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer.

Migotto A, Carvalho V, Salata G, da Silva F, Yan C, Ishida K Drug Deliv. 2018; 25(1):654-667.

PMID: 29495885 PMC: 7011997. DOI: 10.1080/10717544.2018.1440665.

References

Melagraki G, Afantitis A, Igglessi-Markopoulou O, Detsi A, Koufaki M, Kontogiorgis C . Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem. 2009; 44(7):3020-6. DOI: 10.1016/j.ejmech.2008.12.027. View

Lopes L . Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014; 6(1):52-77. PMC: 3978525. DOI: 10.3390/pharmaceutics6010052. View

Zielinska K, Wilk K, Jezierski A, Jesionowski T . Microstructure and structural transition in microemulsions stabilized by aldonamide-type surfactants. J Colloid Interface Sci. 2008; 321(2):408-17. DOI: 10.1016/j.jcis.2008.02.016. View

Lau W, White A, Heard C . Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining. Pharm Res. 2010; 27(12):2734-42. DOI: 10.1007/s11095-010-0274-8. View

Zhang J, Michniak-Kohn B . Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine. Int J Pharm. 2011; 421(1):34-44. DOI: 10.1016/j.ijpharm.2011.09.014. View

Sintov A, Friedman Y, Tamarkin D . Percutaneous penetration and skin metabolism of ethylsalicylate-containing agent, TU-2100: in-vitro and in-vivo evaluation in guinea pigs. J Control Release. 2002; 79(1-3):113-22. DOI: 10.1016/s0168-3659(01)00531-4. View

Gonzalez-Perez O, Moy-Lopez N, Guzman-Muniz J . [Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine]. Rev Invest Clin. 2008; 60(1):58-67. View

Hathout R, Mansour S, Mortada N, Geneidi A, Guy R . Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Mol Pharm. 2010; 7(4):1266-73. DOI: 10.1021/mp100068s. View

Djekic L, Primorac M . The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. Int J Pharm. 2007; 352(1-2):231-9. DOI: 10.1016/j.ijpharm.2007.10.041. View

10.

Lehmann L, Keipert S, Gloor M . Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm. 2001; 52(2):129-36. DOI: 10.1016/s0939-6411(01)00160-6. View

11.

Voegeli D . The effect of washing and drying practices on skin barrier function. J Wound Ostomy Continence Nurs. 2008; 35(1):84-90. DOI: 10.1097/01.WON.0000308623.68582.d7. View

12.

Rachakonda V, Yerramsetty K, Madihally S, Robinson Jr R, Gasem K . Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin. Pharm Res. 2008; 25(11):2697-704. DOI: 10.1007/s11095-008-9696-y. View

13.

Herwadkar A, Sachdeva V, Taylor L, Silver H, Banga A . Low frequency sonophoresis mediated transdermal and intradermal delivery of ketoprofen. Int J Pharm. 2011; 423(2):289-96. DOI: 10.1016/j.ijpharm.2011.11.041. View

14.

Rozman B, Gasperlin M, Tinois-Tessoneaud E, Pirot F, Falson F . Simultaneous absorption of vitamins C and E from topical microemulsions using reconstructed human epidermis as a skin model. Eur J Pharm Biopharm. 2008; 72(1):69-75. DOI: 10.1016/j.ejpb.2008.10.004. View

15.

Lv F, Zheng L, Tung C . Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm. 2005; 301(1-2):237-46. DOI: 10.1016/j.ijpharm.2005.06.006. View

16.

Spiclin P, Gasperlin M, Kmetec V . Stability of ascorbyl palmitate in topical microemulsions. Int J Pharm. 2001; 222(2):271-9. DOI: 10.1016/s0378-5173(01)00715-3. View

17.

Panchagnula R, Desu H, Jain A, Khandavilli S . Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. J Pharm Sci. 2004; 93(9):2177-83. DOI: 10.1002/jps.20140. View

18.

Abdulmajed K, Heard C . Topical delivery of retinyl ascorbate co-drug. 1. Synthesis, penetration into and permeation across human skin. Int J Pharm. 2004; 280(1-2):113-24. DOI: 10.1016/j.ijpharm.2004.05.008. View

19.

Poljsak B, Dahmane R . Free radicals and extrinsic skin aging. Dermatol Res Pract. 2012; 2012:135206. PMC: 3299230. DOI: 10.1155/2012/135206. View

20.

Suppasansatorn P, Nimmannit U, Conway B, Du L, Wang Y . Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). J Pharm Pharmacol. 2007; 59(6):787-94. DOI: 10.1211/jpp.59.6.0005. View